Global Switches Might Be Easier As Governments Seek To Cut Expenditures
This article was originally published in The Tan Sheet
Countries struggling to balance budgets might lower regulatory hurdles for Rx-to-OTC switches to cut their health care spending, consultant Nicholas Hall predicts.
You may also be interested in...
FDA drug center chief Janet Woodcock says behind-the-counter switches would be the most effective method to make Rx drugs available without prescriptions, particularly to help treat chronic conditions.
Limited data protection and a lack of trust between industry and regulators are dampening enthusiasm for the European Union's centralized switch process, according to industry leaders